Share this @internewscast.com
As we enter the colder months in Australia, COVID-19 is making headlines again, this time due to the emergence of a new variant: NB.1.8.1.
Last week, the World Health Organization (WHO) designated NB.1.8.1 as a “variant under monitoring”, owing to its growing global spread and some notable characteristics which could set it apart from earlier variants.

So, what do you need to know about this new variant?

The current COVID-19 situation

More than five years since COVID-19 was initially declared a pandemic, we’re still experiencing regular waves of infections.

It’s more difficult to track the occurrence of the virus nowadays, as fewer people are testing and reporting infections. But available data suggests in late May 2025, case numbers in Australia were ticking upwards.

Genomic sequencing has confirmed NB.1.8.1 is among the circulating strains in Australia, and is generally increasing. Of cases sequenced up to 6 May across Australia, NB.1.8.1 ranged from less than 10 per cent in South Australia to more than 40 per cent in Victoria.
Wastewater surveillance in Western Australia has determined NB.1.8.1 is now the dominant variant in wastewater samples collected in Perth.
Internationally, NB.1.8.1 is also growing. By late April 2025, it comprised roughly 10.7 per cent of all submitted sequences — up from just 2.5 per cent four weeks before. While the absolute number of cases sequenced was still modest, this consistent upward trend has prompted closer monitoring by international public health agencies.

NB.1.8.1 has been spreading particularly in Asia — it was the dominant variant in Hong Kong and China at the end of April.

Where does this variant come from?

According to the WHO, NB.1.8.1 was first detected in samples collected in January 2025.

It’s a sublineage of the Omicron variant, descending from the recombinant XDV lineage. “Recombinant” is where a new variant arises from the genetic mixing of two or more existing variants.

What does the research say?

Like its predecessors, NB.1.8.1 carries a suite of mutations in the spike protein. This is the protein on the surface of the virus that allows it to infect us, specifically via the ACE2 receptors, a “doorway” to our cells.

The mutations include T22N, F59S, G184S, A435S, V445H, and T478I. It’s early days for this variant, so we don’t have much data on what these changes mean yet. But a recent preprint (a study that has not yet been peer-reviewed) offers some clues about why NB.1.8.1 may be gathering traction.

Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested — suggesting it may infect cells more efficiently than earlier strains.
The study also looked at how well antibodies from vaccinated or previously infected people could neutralise or “block” the variant. Results showed the neutralising response of antibodies was around 1.5 times lower against NB.1.8.1 compared to another recent variant, LP.8.1.1.

This means it’s possible a person infected with NB.1.8.1 may be more likely to pass the virus on to someone else, compared to earlier variants.

What are the symptoms?

The evidence so far suggests NB.1.8.1 may spread more easily and may partially sidestep immunity from prior infections or vaccination. These factors could explain its rise in sequencing data.
But importantly, the WHO has not yet observed any evidence it causes more severe disease compared to other variants.
Reports suggest symptoms of NB.1.8.1 should align closely with other Omicron subvariants.

Common symptoms include sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion. Gastrointestinal symptoms may also occur in some cases.

How about the vaccine?

There’s potential for this variant to play a significant role in Australia’s winter respiratory season. Public health responses remain focused on close monitoring, continued genomic sequencing, and promoting the uptake of updated COVID-19 boosters.
Even if neutralising antibody levels are modestly reduced against NB.1.8.1, the WHO has noted COVID-19 vaccines should still protect against severe disease with this variant.
The most recent booster available in Australia and many other countries targets JN.1, from which NB.1.8.1 is descended. So it makes sense that it should still offer good protection.
Ahead of winter and with a new variant on the scene, now may be a good time to consider another COVID-19 booster if you’re eligible. For some people, particularly those who are medically vulnerable, COVID-19 can still be a serious disease.
The Conversation Lara Herrero receives funding from the National Health and Medical Research Council.

Share this @internewscast.com
You May Also Like
Police are appealing for witnesses to come forward after a girl was hit and run over by a dirt bike in Sydney's far south-west yesterday.

Search for Motorcyclist After Dirt Bike Incident Involving 9-Year-Old Girl

Police are appealing for witnesses to come forward after a girl was…
Man charged over alleged $20 million cocaine plot

Man Accused in Alleged $20 Million Cocaine Scheme

A man is set to appear in court later this year, following…

“The Hidden Impact on Australian Shoppers by General Pants and SurfStitch”

There will be more to come on this story in Dateline’s two-part…
Missing surfer Darcy Deefholts

Teen Surfer, 19, Discovered Stranded on Island 12km Off Coast

A missing surfer who disappeared from the New South Wales coast yesterday…
Carolina Wilga, 26, has been backpacking across Australia for the past two years and has most recently been working at mines in regional parts of WA to fund her stays at hostels. 

Intensified Efforts to Locate Missing Backpacker in the Outback Following Discovery of Abandoned Van

Authorities across all states and territories are currently searching for 26-year-old Carolina…

Ireland’s Ben Healy Clinches Solo Victory in Tour de France Stage Six

Ireland’s Ben Healy won stage six of the Tour de France in…

Melbourne’s Oldest Bookshop Gets a New Home with Help from Hundreds

Book by book, hand to hand — hundreds formed a human chain…
t's an Amazon nightmare. Imagine hundreds of oversized packages appear on your doorstep -- and you have no clue why. You never ordered them.

“Hundreds of Misdelivered Packages Turn Woman’s Life into Chaos”

It’s an Amazon nightmare. Imagine hundreds of oversized packages appearing on your…
Nutella maker Ferrero plans to buy cereal maker WK Kellogg for $3.1b

Ferrero, the company behind Nutella, is set to acquire the cereal manufacturer WK Kellogg for $3.1 billion.

Italian confectioner Ferrero, renowned for its Nutella and Kinder brands, is acquiring…
Bluey coin

Bluey Thieves Await Judgment After Stealing 63,000 Coins

Two men are set to spend several months in jail awaiting their…
Sabrina wanted to make some extra cash but ended up broke.

Sabrina Tried a Popular Side Hustle for Extra Cash, But It Ended Badly

Exclusive: Sabrina wanted to make some extra cash. Chloe* followed other local…
Police probing mystery death at popular Adelaide beach

Authorities Investigating Unexplained Death at Well-Known Adelaide Beach

A young man’s death at a beach in Adelaide’s southern suburbs remains…